UDC

611.2

DOI

10.37482/2687-1491-Z104

Authors

Kirill F. Borchev* ORCID: https://orcid.org/0000-0001-5541-8402
*Kaliningrad State Technical University (Kaliningrad, Russian Federation)
Corresponding author: Kirill Borchev, address: ul. Letnyaya 3, Kaliningrad, 236005, Russian Federation; e-mail: k.f.borchev@gmail.com

Abstract

Breath-holding tests are a simple way to determine the state of the respiratory system in patients with respiratory pathology. The aim of this study was to evaluate voluntary breath-holding time in COVID-19 survivors, taking into account the socio-demographic and clinical characteristics. Materials and methods. The study involved patients aged 46 to 84 years with a complication in the form of bilateral multisegmental pneumonia after COVID-19 who were admitted for aftercare to the second stage respiratory rehabilitation department of the Central City Clinical Hospital in Kaliningrad. The subjects were divided into urban and rural residents, as well as by age and sex, presence of concomitant diseases and degree of damage to the lung tissue (based on computed tomography data). Voluntary inspiratory breath-holding time was estimated. Results. All of the patients after COVID-19 (n = 367) showed decreased voluntary inspiratory breath-holding time (mean value 16.9 ± 6.7 s). The degree of damage to the lung tissue had a significant negative impact on voluntary inspiratory breath-holding time, irrespective of the patients’ sex, age, place of residence and concomitant diseases: patients with less than 50 % lung tissue involvement (n = 164) on average held their breath significantly longer (by 17 %, p < 0.001) than patients with more than 50 % lung tissue involvement (n = 203). Men (n = 125) were able to hold their breath longer (by 23 %, p < 0.05) than women (n = 242), while patients from rural areas (n = 91) longer (by 26 %, p = 0.004) than urban residents (n = 276). Concomitant pathologies had a negative cumulative effect on the test results.

Keywords

respiratory dysfunction, pulmonary complications, novel coronavirus infection, consequences of COVID-19, inspiratory breath-holding time test

References

1. Nannini L.J., Zaietta G.A., Guerrera A.J., Varela J.A., Fernández O.M., Flores D.M. Breath-Holding Test in Subjects with Near-Fatal Asthma. A New Index for Dyspnea Perception // Respir. Med. 2007. Vol. 101, № 2. P. 246–253. DOI: 10.1016/j.rmed.2006.05.013
2. Barnai M., Laki I., Gyurkovits K., Angyan L., Horvath G. Relationship Between Breath-Hold Time and Physical Performance in Patients with Cystic Fibrosis // Eur. J. Appl. Physiol. 2005. Vol. 95, № 2. P. 172–178. DOI: 10.1007/s00421-005-1350-3
3. Hedhli A., Slim A., Ouahchi Y., Mjid M., Koumenji J., Cheikh Rouhou S., Toujani S., Dhahri B. Maximal Voluntary Breath-Holding Tele-Inspiratory Test in Patients with Chronic Obstructive Pulmonary Disease // Am. J. Men’s Health. 2021. Vol. 15, № 3. Art. № 15579883211015857. DOI: 10.1177/15579883211015857
4. Trembach N., Zabolotskikh I. Breath-Holding Test in Evaluation of Peripheral Chemoreflex Sensitivity in Healthy Subjects // Respir. Physiol. Neurobiol. 2017. Vol. 235. P. 79–82. DOI: 10.1016/j.resp.2016.10.005
5. Slim A., Hedhli A., Rouhou S.C., Mbarek N., Taboubi A., Benkhaled S., Ouahchi Y., Cherif J., Mjid M., Toujani S., Merai S. Maximal Voluntary Inspiratory Breath Holding Time Test in Patients with Chronic Obstructive Pulmonary Disease // Eur. Respir. J. 2018. Vol. 52, № 62. DOI: 10.1183/13993003.congress-2018.PA4053
6. Ideguchi H., Ichiyasu H., Fukushima K., Okabayashi H., Akaike K., Hamada S., Nakamura K., Hirosako S., Kohrogi H., Sakagami T., Fujii K. Validation of a Breath-Holding Test as a Screening Test for Exercise-Induced Hypoxemia in Chronic Respiratory Diseases // Chron. Resp. Dis. 2021. Vol. 18. Art. № 14799731211012965. DOI: 10.1177/14799731211012965
7. Messineo L., Perger E., Corda L., Joosten S.A., Fanfulla F., Pedroni L., Terrill P.I., Lombardi C., Wellman A., Hamilton G.S., Malhotra A., Vailati G., Parati G., Sands S.A. Breath-Holding as a Novel Approach to Risk Stratification in COVID-19 // Crit. Care. 2021. Vol. 25, № 1. Art. № 208. DOI: 10.1186/s13054-021-03630-5
8. Milyukov V.E., Zharikova T.S. Kriterii formirovaniya vozrastnykh grupp patsientov v meditsinskikh issledovaniyakh [Criteria for the Formation of Age Groups of Patients in Clinical Studies]. Klinicheskaya meditsina, 2015, no. 11, pp. 5–11.
9. Temporary Guidelines: Prevention, Diagnosis and Treatment of the Novel Coronavirus Infection (COVID-19). Version 14 (27.12.2021). Ministry of Health of the Russian Federation. Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/059/041/original/VMR_COVID-19_V14_27-12-2021.pdf (accessed 11 August 2022) (in Russ.).
10. Zabolotskikh I.B., Shifman E.M. (eds.). Anesteziologiya-reanimatologiya: klinicheskie rekomendatsii [Anaesthesiology and Intensive Care Medicine: Clinical Guidelines]. Moscow, 2016. 947 p.
11. Bubnova M.G., Shlyakhto E.V., Aronov D.M., Belevsky A.S., Gerasimenko M.Yu., Glezer M.G., Gordeev M.N., Drapkina O.M., Ivanova G.E., Ioseliani D.G., Karamnova N.S., Kosmacheva E.D., Kuleshov A.V., Kukshina A.A., Lyadov K.V., Lyamina N.P., Makarova M.R., Meshcheryakova N.N., Nikityuk D.B., Pasechnik I.N., Persiyanova-Dubrova A.L., Pogonchenkova I.V., Svet A.V., Starodubova A.V., Tutelian V.A. Coronavirus Disease 2019: Features of Comprehensive Cardiac and Pulmonary Rehabilitation. Russ. J. Cardiol., 2021, vol. 26, no. 5. Art. no. 4487. DOI: 10.15829/1560-4071-2021-4487
12. Borchev K.F., Bondarev D.V., Muromtsev A.B., Pechenaya N.V. Izmeneniya dykhatel’noy i fizicheskoy funktsiy u patsientov srednego i pozhilogo vozrasta, perenesshikh COVID-19, posle programmy kompleksnoy reabilitatsii [Changes in Respiratory Function and Physical Performance in Middle-Aged and Old Inpatients Recovering from Covid-19 After a Rehabilitation Program]. Uspekhi gerontologii, 2021, vol. 34, no. 6, pp. 934–940. DOI: 10.34922/AE.2021.34.6.016
13. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China // Lancet. 2020. Vol. 395, № 10223. P. 497–506. DOI: 10.1016/S0140-6736(20)30183-5
14. Donina Zh.A. Prichiny gipoksemii pri COVID-19 [Causes of Hypoxemia in COVID-19]. Rossiyskiy fiziologicheskiy zhurnal im. I.M. Sechenova, 2022, vol. 108, no. 1, pp. 3–12.
DOI: 10.31857/S0869813922010058
15. Savushkina O.I., Malashenko M.M., Chernyak A.V., Kryukov E.V., Sinitsyn E.A., Zykov K.A. Issledovanie sily dykhatel’nykh myshts u bol’nykh, perenesshikh COVID-19 [Respiratory Muscle Strength in Patients After COVID-19]. Meditsina ekstremal’nykh situatsiy, 2021, vol. 23, no. 3, pp. 55–60. DOI: 10.47183/mes.2021.025
16. Belkin A.A., Avdyunina I.A., Varako N.A., Zinchenko Yu.P., Voznyuk I.A., Davydova N.S., Zabolotskikh I.B., Ivanova G.E., Kondrat’ev A.N., Leyderman I.N., Lubnin A.Yu., Petrikov S.S., Piradov M.A., Protsenko D.N., Stakhovskaya L.V., Suvorov A.Yu., Suponeva N.A., Shamalov N.A., Shchegolev A.V. Reabilitatsiya v intensivnoy terapii. Klinicheskie rekomendatsii [Rehabilitation in Intensive Therapy: Clinical Recommendations]. Vestnik vosstanovitel’noy meditsiny, 2017, no. 2, pp. 139–143.
17. Nishino T. Pathophysiology of Dyspnea Evaluated by Breath-Holding Test: Studies of Furosemide Treatment // Respir. Physiol. Neurobiol. 2009. Vol. 167, № 1. P. 20–25. DOI: 10.1016/j.resp.2008.11.007
18. Abdurakhmanov R.Sh. Fiziologicheskie aspekty gipoksii nagruzki [Physiological Aspects of Tension Hypoxia]. Biomeditsina (Baku), 2004, no. 1, pp. 3–9.
19. Nikolaev A.Yu. Fizicheskaya aktivnost’ i malopodvizhnoe povedenie vzroslykh v gorode i na sele po dannym oprosnika IPAQ [Physical Activity and Sedentary Behaviour of Adults in the City and in the Countryside According to IPAQ]. Aktual’nye problemy gumanitarnykh i estestvennykh nauk, 2017, no. 3-2, pp. 89–93.
20. Rodrigues A., Muñoz Castro G., Jácome C., Langer D., Parry S.M., Burtin C. Current Developments and Future Directions in Respiratory Physiotherapy // Eur. Resp. Rev. 2020. Vol. 29, № 158. Art. № 200264. DOI: 10.1183/16000617.0264-2020